Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Are the Projected Market Size and Growth Rates for the Fecal Microbiota Transplantation (FMT) Market From 2025 To 2029?
The market size for fecal microbiota transplantation (FMT) has seen significant growth over the past few years. There’s an expected increase from $0.85 billion in 2024 to $0.91 billion in 2025, with a compound annual growth rate (CAGR) of 7.2%. The historic growth can be attributed to factors such as heightened awareness of gut microbiome, the expansion of therapeutic applications, an increase in personalized medicine, the adoption of the practice in gastroenterology, a rise in the number of clinical trials, and a surge in funding and investments.
What Is the Projected Market Size of the Fecal Microbiota Transplantation (FMT) Market?
Expectations indicate a significant surge in the fecal microbiota transplantation (FMT) market over the approaching years, with projections suggesting it will reach $1.19 billion by 2029 at a CAGR of 6.9%. This predicted growth within the period can be attributed to factors such as an increased occurrence of clostridium difficile infections (CDI), a rising trend in inflammatory bowel diseases, augmented research and developments, an increasing elderly population, and a growing healthcare infrastructure. Major trends predicted during the forecast period include establishing standardized protocols for donor screening and stool preparation, advancements in the analysis of microbiomes, improved technologies for stool processing, innovative delivery methods, and synthetic or standardized microbiota-based product development.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19430&type=smp
Who are the Major Competitors in the Fecal Microbiota Transplantation (FMT) Market Outlook?
Major companies operating in the fecal microbiota transplantation (FMT) market are Ferring Pharmaceuticals, Johns Hopkins Medicine, Seres Therapeutics, Taconic Biosciences, Enterome, Rebiotix Inc., Finch Therapeutics Group Inc., Locus Biosciences, Yeda Research and Development Co. Ltd., Microbiotica Limited, CosmosID Inc., AOBiome, Synthetic Biologics Inc., Osel Inc., OpenBiome, Asia Microbiota Bank, Taymount Clinic, MicroBiome Therapeutics LLC, MaaT Pharma SA, Kallyope
What Is Fueling Growth in the Fecal Microbiota Transplantation (FMT) Market?
The growth of the fecal microbiota transplantation (FMT) market is expected to be driven by an increasing number of gastrointestinal disorders. These disorders encompass a variety of conditions affecting different parts of the gastrointestinal tract – from the esophagus, stomach, and intestines, to the colon, rectum, and anus. This surge in gastrointestinal issues is attributed to rising stress levels, a lack of physical activity, and the overconsumption of processed foods. Fecal microbiota transplantation is a technique used to reinstate healthy gut bacteria, especially useful in treating recurring Clostridioides difficile infections. Crohn’s and Colitis Canada, a non-profit organization based in Canada, projected in 2023 that the rapidly growing number of people suffering from IBD in Canada would rise from 322,600 in 2023 (0.8% of the population) to 470,000 in 2035 (1.1% of the population). It was estimated that 11,000 people would be diagnosed in 2023 (one every 48 minutes), a number that will increase to 14,000 by 2035 (one new case every 38 minutes). Hence, this escalating prevalence of gastrointestinal disorders is a major factor in propelling the growth of the fecal microbiota transplantation (FMT) market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=19430&type=smp
Which Fecal Microbiota Transplantation (FMT) Market Segments Are Growing the Fastest?
The fecal microbiota transplantation (FMT) market covered in this report is segmented –
1) By Type: Fermentation, Fresh, Cryopreservation
2) By Donor Type: Stool-Derived, Fecal-Derived, Whole-Microbiome Derived
3) By Indication: Clostridioides Difficile Infection, Inflammatory Bowel Disease, Metabolic Syndrome, Other Indications
4) By Administration Route: Oral, Rectal, Nasogastric, Colon Capsule
5) By End-User: Hospitals, Specialty Clinics, Other End-Users
Subsegments:
1) By Fermentation: Fermented FMT Products, Fermented Capsules, Fermented Liquids, In-House Fermentation Techniques
2) By Fresh: Fresh Stool Samples, Fresh FMT Capsules, Fresh FMT Solutions for In-Hospital Use, Freshly Prepared FMT for Outpatient Use
3) By Cryopreservation: Cryopreserved Stool Samples, Cryopreserved FMT Capsules, Cryopreserved Liquid FMT, Long-Term Storage Solutions for Cryopreserved FMT
Which Industry Trends Are Shaping the Future of the Fecal Microbiota Transplantation (FMT) Market?
Leading businesses in the fecal microbiota transplantation (FMT) market are directing their efforts towards creating innovative solutions such as microbiota-based live biotherapeutics, to improve the treatment effectiveness for gastrointestinal conditions. Such live biotherapeutics include living microorganisms that function as therapeutic agents to adjust or restore the gut microbiome in treating different ailments. In November 2022, for example, Ferring Pharmaceuticals, a biopharmaceutical firm based in Switzerland, gained approval from the US Food and Drug Administration (FDA) for their pioneering first-in-class microbiota-based live biotherapeutic, REBYOTA (fecal microbiota, live-jslm). REBYOTA, intended to prevent the recurrence of Clostridioides difficile infection (CDI) in those aged 18 or over following antibiotic treatment for recurrent CDI, breaks new ground in the field. Specifically, REBYOTA is designed to prevent Clostridioides difficile (C. difficile) infection from recurring in people over 18 who have undergone antibiotic treatment for recurrent CDI.
Access The Full Report Here:
Which Countries Are Leading the Fecal Microbiota Transplantation (FMT) Market?
North America was the largest region in the fecal microbiota transplantation (FMT) market in 2024. The regions covered in the fecal microbiota transplantation (FMT) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19430
This Report Delivers Insight On:
1. How big is the fecal microbiota transplantation (fmt) market, and how is it changing globally?
2. Who are the major companies in the fecal microbiota transplantation (fmt) market, and how are they performing?
3. What are the key opportunities and risks in the fecal microbiota transplantation (fmt) market right now?
4. Which products or customer segments are growing the most in the fecal microbiota transplantation (fmt) market?
5. What factors are helping or slowing down the growth of the fecal microbiota transplantation (fmt) market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model